Amalgam Rx Partners With Biolinq to Power FDA-Cleared Needle-Free Glucose Sensor
WILMINGTON, DE — Amalgam Rx, Inc. has announced a collaboration with Biolinq Incorporated to develop the digital infrastructure behind Biolinq Shine™, the first fully autonomous, needle-free glucose sensor recently granted …
Amalgam Rx Partners With Biolinq to Power FDA-Cleared Needle-Free Glucose Sensor Read More